Novel insights into the delayed vasospasm following subarachnoid haemorrhage: importance of proteinase signalling
Open Access
- 6 December 2011
- journal article
- editorial
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (1) , 103-105
Abstract
This article summarizes the findings of Kameda et al. (this issue of BJP) that suggest a new avenue for the pharmacological treatment of subarachnoid haemorrhage (SAH) involving the combined use of a proteinase inhibitor (argatroban) that targets thrombin and an antioxidant (vitamin C). The findings are presented in the context of previous modalities of treating SAH that are of modest impact and the possibility that inhibiting proteinase‐mediated signalling via proteinase‐activated receptors like the thrombin PAR1 receptor combined with blocking oxidative stress may provide a new avenue for the treatment of SAH.LINKED ARTICLE This article is a commentary on Kameda et al., pp. 106–119 of this issue. To view this paper visit http://dx.doi.org/10.1111/j.1476‐5381.2011.01485.xKeywords
This publication has 16 references indexed in Scilit:
- Structure, function and pathophysiology of protease activated receptorsPharmacology & Therapeutics, 2011
- Combined argatroban and anti‐oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhageBritish Journal of Pharmacology, 2011
- Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thoughtNeurological Research, 2009
- Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanisms and novel approachesJournal of Neuroscience Research, 2008
- Proteinases and signalling: pathophysiological and therapeutic implications via PARs and moreBritish Journal of Pharmacology, 2008
- Proteinase-activated Receptors, Targets for Kallikrein SignalingJournal of Biological Chemistry, 2006
- Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa studyJournal of Neurosurgery, 2005
- Proteinase-activated receptors in the nervous systemNature Reviews Neuroscience, 2003
- International Union of Pharmacology. XXVIII. Proteinase-Activated ReceptorsPharmacological Reviews, 2002
- Therapeutic Trial of Cerebral Vasospasm with the Serine Protease Inhibitor, FUT-175, Administered in the Acute Stage after Subarachnoid HemorrhageNeurosurgery, 1992